Immune Cell Therapy

Applicable diseases: Malignant melanoma, ovarian cancer, colon cancer, breast cancer, cervical cancer, lung cancer, liver cancer, stomach cancer, and other malignancies.

Technology advantages: Works by regulating the body’s own immune system to strengthen its anticancer response, offering broad-spectrum activity against multiple tumor types, long-lasting therapeutic effect, and comparatively low toxicity.

The Current State of Cancer Treatment

Cancer remains one of the most serious threats to human health due to its highly malignant nature. Global health statistics indicate that, on average, a new cancer diagnosis occurs roughly every four seconds, and approximately 8.2 million people worldwide lose their lives to the disease each year. Projections suggest that cancer mortality could double by 2030 if current trends continue.

Despite these figures, a cancer diagnosis does not automatically equate to a death sentence. Analysis of cancer-related deaths suggests that around 63% may be linked to shortcomings in medical management rather than the disease itself. Standard treatment approaches — including surgical resection, radiotherapy, and chemotherapy — are designed to destroy malignant cells, but in the process they frequently damage healthy tissue as well, which can accelerate a patient’s decline rather than support recovery.

Contributing Factors Behind Treatment-Related Deaths

• Errors made during the course of treatment
• Substandard quality of medical care
• Misunderstanding of the disease or treatment plan
• Delays in starting treatment
• Patients discontinuing treatment prematurely
• Financial constraints preventing adequate care

*Data referenced from Cancer Review.

Why Consider Immune Cell Therapy?

Conventional cancer treatments tend to target malignant cells directly without addressing the underlying reasons those cells were able to develop and spread in the first place. These treatments can also compromise a patient’s immune defenses. According to Ralph Marvin Steinman, recipient of the 2011 Nobel Prize in Physiology or Medicine, the most effective long-term strategy may be to restore and strengthen a patient’s own immune system so that it can eliminate cancer cells naturally.

Steinman’s Nobel-winning research identified dendritic cells and clarified their essential function within the immune response. Following his discovery, two additional researchers were later recognized with Nobel Prizes for related work in immune cell biology. These breakthroughs have driven a growing number of oncology specialists to incorporate immune cell therapy into cancer care, offering new hope to patients worldwide.

How Cancer Develops in the Body

Under normal circumstances, the human body generates somewhere between 6,000 and 10,000 abnormal (potentially cancerous) cells every single day. A healthy immune system typically identifies and destroys these cells before they can cause harm. However, when immune function is weakened, the body’s ability to clear these abnormal cells diminishes. Over time, surviving abnormal cells can multiply, damage surrounding healthy tissue, and eventually form a tumor mass.

Three Stages of Cancer Progression

1. The immune system successfully detects and eliminates abnormal cells before they pose any health risk.
2. The immune system destroys some abnormal cells, but others evade detection and survive, resulting in a temporary balance between cancerous and normal cells.
3. Surviving abnormal cells escape immune surveillance entirely and begin to proliferate, eventually forming a tumor that becomes clinically detectable. At this stage, the immune system can no longer contain or slow the tumor’s growth on its own.

How Immune Cell Therapy Works

Immune cell therapy takes a fundamentally different approach to fighting cancer by rebuilding and enhancing the body’s natural immune response, rather than directly attacking tumor cells with external agents. The process generally unfolds across five stages.

1. Immune cells are directed rapidly toward tumor tissue, establishing a targeted response against the malignancy.
2. The therapy works to maximize overall immune strength, helping to suppress further tumor growth.
3. It alters the microenvironment surrounding cancer cells, making conditions less favorable for their continued development.
4. The nutrient supply that tumors rely on is disrupted, reducing their metabolic activity.
5. As these effects accumulate, tumor progression slows, eventually halts, and cancer cells begin to die off.

Key Advantages of Immune Cell Therapy

• Because it works with the body’s own immune mechanisms, this therapy has the potential to offer more durable protection against cancer than many conventional treatments, generally without significant side effects.
• It supports a systemic, whole-body approach to fighting cancer rather than a purely localized one.
• The immune system is trained to selectively recognize and destroy cancerous cells while sparing healthy tissue.
• Once activated, immune protection can persist over the long term.
• It can be applied across a wide range of cancer types.

Clinical Applications of Immune Cell Therapy

Before Surgery: Improving Surgical Success Rates

For patients diagnosed at an early stage, immune cell therapy can help strengthen overall immune function ahead of surgery, helping to offset the temporary immune suppression that surgical procedures often cause. This, in turn, can contribute to improved surgical outcomes.

Combined Use: Enhancing Comprehensive Treatment Outcomes

For patients in the middle to advanced stages of cancer, immune cell therapy can be integrated with other treatment modalities — such as radiotherapy, chemotherapy, cryotherapy, or interventional therapy — to achieve a more comprehensive and effective treatment outcome.

After Surgery: Reducing Residual Cancer Cells and Recurrence Risk

Patients who have already undergone radiotherapy, chemotherapy, or minimally invasive procedures may benefit from immune cell therapy as a follow-up step, helping the body rebuild and strengthen its antitumor defenses, clear remaining cancer cells, and lower the likelihood of recurrence or metastasis.

Standalone Use: A Preventive Strategy

Individuals with a family history of cancer, or those who have previously been treated for the disease, may consider immune cell therapy on a regular basis as a preventive measure. The therapy is designed to help the immune system recognize, seek out, and eliminate abnormal or diseased cells before they progress, supporting long-term immune resilience.

Cancer Types That May Benefit from This Therapy

Immune cell therapy may be considered as a supportive or follow-up treatment for the following cancer types, with the goal of extending survival time and improving overall quality of life:

• Malignant melanoma
• Prostate cancer
• Kidney cancer
• Bladder cancer
• Ovarian cancer
• Colon and rectal cancer
• Breast cancer
• Cervical cancer
• Lung cancer
• Throat cancer
• Nasopharyngeal cancer
• Pancreatic cancer
• Liver cancer
• Stomach cancer

Note: Not all patients are suitable candidates for immune cell therapy. Suitability should be assessed on a case-by-case basis in consultation with an oncology specialist.